Biotech Industry Offers New Opportunities For Overseas Returnees
This article was originally published in PharmAsia News
Executive SummaryArmed with advanced technical skills and resources, an international perspective, and foreign contacts, overseas returnees are being offered new opportunities by China's burgeoning biotechnology industry
You may also be interested in...
The first phase of a major trade agreement just signed by the US and China obliges the latter to implement a system linking pharma patent enforcement to marketing authorization procedures as well as to offer patent-term extensions.
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.